100 related articles for article (PubMed ID: 9867530)
1. Association of mutations in the apolipoprotein B gene with hypercholesterolemia and the risk of ischemic heart disease.
Schaefer JR; Herzum M; Maisch B
N Engl J Med; 1998 Nov; 339(22):1641-2. PubMed ID: 9867530
[No Abstract] [Full Text] [Related]
2. Association of mutations in the apolipoprotein B gene with hypercholesterolemia and the risk of ischemic heart disease.
Tybjaerg-Hansen A; Steffensen R; Meinertz H; Schnohr P; Nordestgaard BG
N Engl J Med; 1998 May; 338(22):1577-84. PubMed ID: 9603795
[TBL] [Abstract][Full Text] [Related]
3. Association of mutations in the apolipoprotein B gene with hypercholesterolemia and the risk of ischemic heart disease.
Gaffney D; Pullinger C; Kane J
N Engl J Med; 1998 Nov; 339(22):1640-1; author reply 1641-2. PubMed ID: 9867529
[No Abstract] [Full Text] [Related]
4. Familial hypercholesterolemia and coronary heart disease: a HuGE association review.
Austin MA; Hutter CM; Zimmern RL; Humphries SE
Am J Epidemiol; 2004 Sep; 160(5):421-9. PubMed ID: 15321838
[TBL] [Abstract][Full Text] [Related]
5. Mutation analysis in 46 German families with familial hypercholesterolemia: identification of 8 new mutations. Mutations in brief no. 226. Online.
Ebhardt M; Schmidt H; Doerk T; Tietge U; Haas R; Manns MP; Schmidtke J; Stuhrmann M
Hum Mutat; 1999; 13(3):257. PubMed ID: 10090484
[TBL] [Abstract][Full Text] [Related]
6. Phenotype of heterozygotes for low-density lipoprotein receptor mutations identified in different background populations.
Tybjaerg-Hansen A; Jensen HK; Benn M; Steffensen R; Jensen G; Nordestgaard BG
Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):211-5. PubMed ID: 15528480
[TBL] [Abstract][Full Text] [Related]
7. [Apolipoprotein E polymorphism, hyperlipidemia and risk of myocardial infarct].
Assmann G; Lenzen HJ
Internist (Berl); 1985 Nov; 26(11):692-700. PubMed ID: 3908375
[No Abstract] [Full Text] [Related]
8. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
Jensen HK
Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
[TBL] [Abstract][Full Text] [Related]
9. Familial defective apolipoprotein B-100 (R3500Q) in Northern Ireland.
McClean E; Graham CA; Ward AJ; Young IS; Martin S; Nicholls DP
Br J Biomed Sci; 1999; 56(4):258-62. PubMed ID: 10795369
[TBL] [Abstract][Full Text] [Related]
10. [Familial defect of apo B-100 in subjects with clinically diagnosed primary hypercholesterolemia: identification of the first family with this disorder in Spain].
Real JT; Chaves JF; Ascaso JF; Armengod ME; Carmena R
Med Clin (Barc); 1999 Jun; 113(1):15-7. PubMed ID: 10422071
[TBL] [Abstract][Full Text] [Related]
11. [Analysis of polymorphism of the 5'-terminal region of apolipoprotein B gene in patients with ischemic heard disease].
Shadrina MI; Slonimskiĭ PA; Oganov RG; Perova NV; Limborskaia SA
Genetika; 1996 Aug; 32(8):1041-4. PubMed ID: 8964475
[TBL] [Abstract][Full Text] [Related]
12. [New knowledge of the pathogenesis of familial hypercholesterolemia].
Beisiegel U; Weber W
Verh Dtsch Ges Inn Med; 1986; 92():383-9. PubMed ID: 2949446
[No Abstract] [Full Text] [Related]
13. [Application of DNA analysis for differential diagnosis of familial hypercholesterolemia and familial defect of apolipoprotein b-100].
Krapivner SR; Malyshev PP; Rozhkova TA; Potaraus AB; Kukharchuk VV; Bochkov VN
Ter Arkh; 2000; 72(4):9-12. PubMed ID: 10833789
[TBL] [Abstract][Full Text] [Related]
14. [Direct detection of mutations in the LDL receptor gene in patients with familial hypercholesterolemia].
Freiberger T; Kuhrová V; Kozák L; Soska V; Pekarík V; Mĕrínská L; Fajkusová L; Francová H
Cas Lek Cesk; 1998 Dec; 137(24):750-2. PubMed ID: 10081189
[TBL] [Abstract][Full Text] [Related]
15. [Apolipoprotein genes in patients with ischemic heart disease].
Baĭtasova NB; Rysmendiev AZh; Shchuratova SG
Klin Med (Mosk); 2001; 79(12):19-21. PubMed ID: 11840804
[TBL] [Abstract][Full Text] [Related]
16. Post-mortem investigation of young deceased individuals with ischemic heart disease-outcome of supplementary genetic testing for dyslipidemia.
Hertz CL; Christiansen SL; Ottesen GL; Frank-Hansen R; Bundgaard H; Morling N
Int J Legal Med; 2016 Jul; 130(4):947-948. PubMed ID: 26490271
[No Abstract] [Full Text] [Related]
17. The effect of apolipoprotein E polymorphism on the response to lipid-lowering treatment with atorvastatin or fenofibrate.
Christidis DS; Liberopoulos EN; Kakafika AI; Miltiadous GA; Cariolou M; Ganotakis ES; Mikhailidis DP; Elisaf MS
J Cardiovasc Pharmacol Ther; 2006 Sep; 11(3):211-21. PubMed ID: 17056835
[TBL] [Abstract][Full Text] [Related]
18. Familial hypercholesterolemia, peripheral arterial disease, and stroke: a HuGE minireview.
Hutter CM; Austin MA; Humphries SE
Am J Epidemiol; 2004 Sep; 160(5):430-5. PubMed ID: 15321839
[TBL] [Abstract][Full Text] [Related]
19. Update of the molecular basis of familial hypercholesterolemia in The Netherlands.
Fouchier SW; Kastelein JJ; Defesche JC
Hum Mutat; 2005 Dec; 26(6):550-6. PubMed ID: 16250003
[TBL] [Abstract][Full Text] [Related]
20. Reconstitution of apoB mRNA editing in liver by gene-transfer as a potential approach for the treatment of severe forms of polygenic hypercholesterolemia--an outline of the rationale.
Greeve J; Chowdhury JR
Z Gastroenterol; 1996 Jun; 34 Suppl 3():27-30. PubMed ID: 8767452
[No Abstract] [Full Text] [Related]
[Next] [New Search]
